Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9274853rdf:typepubmed:Citationlld:pubmed
pubmed-article:9274853lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:9274853lifeskim:mentionsumls-concept:C0006114lld:lifeskim
pubmed-article:9274853lifeskim:mentionsumls-concept:C0021308lld:lifeskim
pubmed-article:9274853lifeskim:mentionsumls-concept:C0079633lld:lifeskim
pubmed-article:9274853lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:9274853lifeskim:mentionsumls-concept:C0035126lld:lifeskim
pubmed-article:9274853lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:9274853pubmed:issue2lld:pubmed
pubmed-article:9274853pubmed:dateCreated1997-9-11lld:pubmed
pubmed-article:9274853pubmed:abstractTextReperfusion after a transient ischemia is a frequently encountered clinical condition that often causes greater tissue damage than persistent ischemia itself. Reperfusion to rabbit brain, after a transient focal ischemia, induced neutrophil infiltration and aggregation--neither of which were observed in rabbit brain rendered ischemic alone for the same time interval--thereby leading to severe brain edema and infarct. Brain tissue levels of interleukin-8 (IL-8), a potent neutrophil chemotactic cytokine (chemokine), increased significantly at 6 hours after reperfusion, but without a noticeable elevation of plasma IL-8 levels. Moreover, we detected IL-8 protein immunohistologically in the vascular wall and, to a lesser degree, in infiltrated neutrophils, suggesting a local production of IL-8 in reperfused brain tissues. Furthermore, a neutralizing anti-IL-8 antibody significantly reduced brain edema and infarct size in comparison to rabbits receiving a control antibody. These results implicate locally produced IL-8 as a pivotal mediator of cerebral reperfusion and suggest that IL-8 is a novel target for the intervention of this injury.lld:pubmed
pubmed-article:9274853pubmed:languageenglld:pubmed
pubmed-article:9274853pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9274853pubmed:citationSubsetIMlld:pubmed
pubmed-article:9274853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9274853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9274853pubmed:statusMEDLINElld:pubmed
pubmed-article:9274853pubmed:monthAuglld:pubmed
pubmed-article:9274853pubmed:issn0023-6837lld:pubmed
pubmed-article:9274853pubmed:authorpubmed-author:MatsumotoTTlld:pubmed
pubmed-article:9274853pubmed:authorpubmed-author:IkedaKKlld:pubmed
pubmed-article:9274853pubmed:authorpubmed-author:YamashitaJJlld:pubmed
pubmed-article:9274853pubmed:authorpubmed-author:MatsumotoYYlld:pubmed
pubmed-article:9274853pubmed:authorpubmed-author:HaradaAAlld:pubmed
pubmed-article:9274853pubmed:authorpubmed-author:MatsushimaKKlld:pubmed
pubmed-article:9274853pubmed:authorpubmed-author:MukaidaNNlld:pubmed
pubmed-article:9274853pubmed:issnTypePrintlld:pubmed
pubmed-article:9274853pubmed:volume77lld:pubmed
pubmed-article:9274853pubmed:ownerNLMlld:pubmed
pubmed-article:9274853pubmed:authorsCompleteYlld:pubmed
pubmed-article:9274853pubmed:pagination119-25lld:pubmed
pubmed-article:9274853pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:meshHeadingpubmed-meshheading:9274853-...lld:pubmed
pubmed-article:9274853pubmed:year1997lld:pubmed
pubmed-article:9274853pubmed:articleTitlePrevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8.lld:pubmed
pubmed-article:9274853pubmed:affiliationDepartment of Neurosurgery, School of Medicine, Kanazawa University, Japan.lld:pubmed
pubmed-article:9274853pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9274853lld:pubmed